Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. (Q36458314)

14 August 2017

1 reference

title

Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. (English)

1 reference

14 August 2017

1 reference

3

1 reference

14 August 2017

4

Mark A Smith

1 reference

14 August 2017

2

Hyoung-Gon Lee

1 reference

14 August 2017

1

Rudy J Castellani

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

American Journal of Alzheimer's Disease & Other Dementias

14 August 2017

published in

1 reference

14 August 2017

volume

21

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

126-130

1 reference

Neuropathological stageing of Alzheimer-related changes

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Alzheimer neuropathologic alterations in aged cognitively normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Gamma-glutamylcysteine ethyl ester protection of proteins from Abeta(1-42)-mediated oxidative stress in neuronal cell culture: a proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Redox-active iron mediates amyloid-beta toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Tau phosphorylation in Alzheimer's disease: pathogen or protector?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

What counts in brain aging? Design-based stereological analysis of cell number

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Ubiquitin is a component of paired helical filaments in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Neurons may live for decades with neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Activation of MKK6, an upstream activator of p38, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Evidence for oxidative stress in Pick disease and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Role of oxidative stress in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Predicting the failure of amyloid-beta vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Arson. Tracking the culprit in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

Neuron loss in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750602100213

10.1177/153331750602100213

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference